Tuesday Aug 12
What The Judge's Award Means For PharmAthene's Value/Share: A Data-Based Analysis
I explain why if SIGA appeals the ruling to the Supreme Court, the Vice Chancellor's opinion will be upheld.
Why SIGA Technologies (SIGA) Stock Plunged to a One-Year Low Today
SIGA announced that the award amount, which has not yet been determined, would be "substantial," but it intends to appeal the ruling.
Why PharmAthene Is Up 56% In #PreMarket Trading
A Delaware court ordered SIGA Technologies to pay lump sum expectation damages to PharmAthene for lost profits relating to SIGA's smallpox antiviral.
Dean Foods says tradedown to private label white milk impacting margins
On The Fly: Pre-market Movers HIGHER: PharmAthene , up 55% after announcing that a Delaware court awarded the company lump sum expectation damages for the value of its lost profits for SIGA Technologies' smallpox antiviral, Tecovirimat... MannKind , up 19% after entering exclusive licensing agreement for development and commercialization of Afrezza ... (more)
Delaware Court of Chancery Orders SIGA To Pay PharmAthene Lump Sum Expectation Damages
Court of Chancery issued a Memorandum Opinion and awarded to PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits for SIGA Technologies, Inc.'s smallpox antiviral, Tecovirimat .
SIGA Technologies' (SIGA) CEO Eric Rose on Q2 2014 Results - Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the SIGA Technologies Quarterly Business Update Call.
PharmAthene Reports Second Quarter 2014 Financial And Operational Results
PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the second quarter of 2014.